ADAP - Adaptimmune readies ADS offering June, 01 2020 06:22 AM Adaptimmune Therapeutics plc Adaptimmune Therapeutics (NASDAQ:ADAP) intends to offer and sell 12.5M American Depositary Shares (ADSs) in a public offering.More news on: Adaptimmune Therapeutics plc, Healthcare stocks news, , Stocks on the move, Read more ...